96 related articles for article (PubMed ID: 11734048)
1. Generation of new enzyme inhibitors using imprinted binding sites: the anti-idiotypic approach, a step toward the next generation of molecular imprinting.
Mosbach K; Yu Y; Andersch J; Ye L
J Am Chem Soc; 2001 Dec; 123(49):12420-1. PubMed ID: 11734048
[No Abstract] [Full Text] [Related]
2. Formation of a class of enzyme inhibitors (drugs), including a chiral compound, by using imprinted polymers or biomolecules as molecular-scale reaction vessels.
Yu Y; Ye L; Haupt K; Mosbach K
Angew Chem Int Ed Engl; 2002 Dec; 41(23):4459-63. PubMed ID: 12458506
[No Abstract] [Full Text] [Related]
3. 1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors.
Gopalsamy A; Yang H; Ellingboe JW; McKew JC; Tam S; Joseph-McCarthy D; Zhang W; Shen M; Clark JD
Bioorg Med Chem Lett; 2006 Jun; 16(11):2978-81. PubMed ID: 16545564
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.
Sun L; Li J; Bera H; Dolzhenko AV; Chiu GN; Chui WK
Eur J Med Chem; 2013; 70():400-10. PubMed ID: 24177367
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
[TBL] [Abstract][Full Text] [Related]
6. Binding efficiency and transport properties of molecularly imprinted polymer thin films.
Duffy DJ; Das K; Hsu SL; Penelle J; Rotello VM; Stidham HD
J Am Chem Soc; 2002 Jul; 124(28):8290-6. PubMed ID: 12105909
[TBL] [Abstract][Full Text] [Related]
7. Non-thiol farnesyltransferase inhibitors: evaluation of different AA(X)-peptidomimetic substructures in combination with arylic cysteine replacements.
Sakowski J; Böhm M; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2002 Apr; 335(4):135-42. PubMed ID: 12112033
[TBL] [Abstract][Full Text] [Related]
8. Double trouble.
Miller WT
Nat Struct Biol; 2001 Jan; 8(1):16-8. PubMed ID: 11135660
[No Abstract] [Full Text] [Related]
9. Plastic antibodies: developments and applications.
Haupt K; Mosbach K
Trends Biotechnol; 1998 Nov; 16(11):468-75. PubMed ID: 9830155
[TBL] [Abstract][Full Text] [Related]
10. Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of D-glutamic acid.
Sosič I; Barreteau H; Simčič M; Sink R; Cesar J; Zega A; Grdadolnik SG; Contreras-Martel C; Dessen A; Amoroso A; Joris B; Blanot D; Gobec S
Eur J Med Chem; 2011 Jul; 46(7):2880-94. PubMed ID: 21524830
[TBL] [Abstract][Full Text] [Related]
11. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 3-(carboxyarylalkyl)imidazo[2,1-f][1,2,4]triazines as potential inhibitors of AMP deaminase.
Kirkman JK; Lindell SD; Maechling S; Slawin AM; Moody CJ
Org Biomol Chem; 2008 Dec; 6(23):4452-9. PubMed ID: 19005607
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3.
Harikrishnan LS; Kamau MG; Wan H; Inghrim JA; Zimmermann K; Sang X; Mastalerz HA; Johnson WL; Zhang G; Lombardo LJ; Poss MA; Trainor GL; Tokarski JS; Lorenzi MV; You D; Gottardis MM; Baldwin KF; Lippy J; Nirschl DS; Qiu R; Miller AV; Khan J; Sack JS; Purandare AV
Bioorg Med Chem Lett; 2011 Mar; 21(5):1425-8. PubMed ID: 21282055
[TBL] [Abstract][Full Text] [Related]
14. 1,3,5-Triazepan-2,6-diones as conformationally constrained dipeptide mimetics. In silico guided identification of sPLA2 inhibitors.
Guichard G; Léna G; Boeglin J; Muller P; Boilard E; Lambeau G; Rognan D; Didierjean C
Adv Exp Med Biol; 2009; 611():201-2. PubMed ID: 19400159
[No Abstract] [Full Text] [Related]
15. Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation.
Maga G; Falchi F; Radi M; Botta L; Casaluce G; Bernardini M; Irannejad H; Manetti F; Garbelli A; Samuele A; Zanoli S; Esté JA; Gonzalez E; Zucca E; Paolucci S; Baldanti F; De Rijck J; Debyser Z; Botta M
ChemMedChem; 2011 Aug; 6(8):1371-89. PubMed ID: 21698775
[TBL] [Abstract][Full Text] [Related]
16. Some new developments and challenges in non-covalent molecular imprinting technology.
Mosbach K; Haupt K
J Mol Recognit; 1998; 11(1-6):62-8. PubMed ID: 10076808
[TBL] [Abstract][Full Text] [Related]
17. Rational design of selective submicromolar inhibitors of Tritrichomonas foetus hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Aronov AM; Munagala NR; Ortiz De Montellano PR; Kuntz ID; Wang CC
Biochemistry; 2000 Apr; 39(16):4684-91. PubMed ID: 10769124
[TBL] [Abstract][Full Text] [Related]
18. Design of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-TRP as an IDO affinity moiety.
Nakashima H; Ikkyu K; Nakashima K; Sano K; Uto Y; Nakata E; Nagasawa H; Sugimoto H; Shiro Y; Nakagawa Y; Hori H
Adv Exp Med Biol; 2010; 662():415-21. PubMed ID: 20204824
[TBL] [Abstract][Full Text] [Related]
19. The design and preliminary structure-activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymes.
Cao J; Fine R; Gritzen C; Hood J; Kang X; Klebansky B; Lohse D; Mak CC; McPherson A; Noronha G; Palanki MS; Pathak VP; Renick J; Soll R; Zeng B; Zhu H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5812-8. PubMed ID: 17827012
[TBL] [Abstract][Full Text] [Related]
20. Molecularly imprinted microgels as enzyme inhibitors.
Cutivet A; Schembri C; Kovensky J; Haupt K
J Am Chem Soc; 2009 Oct; 131(41):14699-702. PubMed ID: 19775079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
